-
Neisseria meningitidis.
Neisseria meningitidis,
often referred to as the
meningococcus, is a Gram-negative
bacterium that can
cause meningitis and
other forms...
-
versions are
effective against some or all of the
following types of
meningococcus: A, B, C, W-135, and Y. The
vaccines are
between 85 and 100% effective...
- a
serious infection caused by
Neisseria meningitidis, also
known as
meningococcus, a gram
negative diplococcus.
Meningococcal disease includes meningitis...
-
combinations with
meningococcus C,
conjugated J07AG54
Haemophilus influenza B,
combinations with
meningococcus C, Y,
conjugated J07AH01
Meningococcus A, purified...
- with
meningitis caused by
meningococci or septicaemia. In particular,
meningococcus (Neisseria meningitidis), a Gram-negative
diplococcus organism, releases...
- pneumoniae.
Attempts at
reverse vaccinology first began with
Meningococcus B (MenB).
Meningococcus B
caused over 50% of
meningococcal meningitis, and scientists...
- all
cases of mumps.
Meningococcus vaccines exist against groups A, B, C, W135 and Y. In
countries where the
vaccine for
meningococcus group C was introduced...
-
group B
meningococcus, used to
control an
epidemic of
meningococcal disease in New Zealand. Most
people are able to
carry the
meningococcus bacteria...
-
infection caused by the
Neisseria meningitidis bacterium,
commonly known as
meningococcus. The
vaccine is
created using bacterial capsular polysaccharides derived...
-
scientist Jane
Hinton at
Harvard University as a
culture for
gonococcus and
meningococcus. They co-published the
method in 1941. Fernández-Mazarrasa, Carlos;...
